Large drugmakers
The 411 large drugmakers we cover, part of healthcare, largest first. Numbers as of .
- Companies
- 411
- Combined market cap
- $4.1T
- Median PE
- 20.7×
- Median revenue growth
- +8.1%
- Median net margin
- −7.5%
The largest 250 of 411.
Rankings of large drugmakers
- Large drugmakers with the lowest PE ratio
- Large drugmakers cheapest against their own PE history
- Large drugmakers with the lowest price to sales ratio
- Large drugmakers with the lowest EV/EBIT
- Large drugmakers with the highest free cash flow yield
- Large drugmakers with the fastest revenue growth
- Large drugmakers with the fastest earnings growth
- Large drugmakers with the highest profit margins
Other industries in Healthcare
Valuation data, not investment advice. Each company's page has its story, charts, financials and peers.